Energy Fuels (TSE:EFR) has released an update.
Energy Fuels Inc. has acquired RadTran LLC, a company specializing in the separation of critical radioisotopes, to bolster its development of medical isotopes for cancer treatment. This strategic move aims to address the global shortage of isotopes used in emerging targeted alpha therapies. The acquisition couples Energy Fuels’ processing capabilities with RadTran’s technology, potentially positioning the company as a leader in the medical radioisotope field.
For further insights into TSE:EFR stock, check out TipRanks’ Stock Analysis page.
